Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK/PD of Apixaban and Edoxaban in Liver Cirrhosis
NCT05869591Phase 2Recruiting
- Sponsor
- Lausanne University Hospital
- Start
- Jan 2024
- Primary completion
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of apixaban, edoxaban in venous thromboembolism (VTE), portal vein thrombosis (PVT), sponsored by Lausanne University Hospital. Started Jan 2024; status: recruiting.
02
Drugs
apixabanedoxaban
03
Conditions
venous thromboembolism (VTE)portal vein thrombosis (PVT)
Beyond the preview
Go deeper on NCT05869591.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05869591.